Drug | Therapeutic target | 3NN ranking (TT) | 3NN ranking (hERG) |
---|---|---|---|
Astemizole | H1 receptor | 3 | 2 |
Cisapride | 5-hydroxytryptamine 2A/3/4 receptor | 5 | 6 |
Sertindole | D2 receptor | 1 | 2 |
5-hydroxytryptamine 2A/2C/6 receptor | 4 | ||
α-hydroxytr adrenergic receptor | 5-7 | ||
terfenadine | Histamine H1 receptor | 2 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 1 | ||
M3 | 5 | ||
Sparfloxacin | DNA topoisomerase 4 subunit A | 2 | 1 |
DNA gyrase subunit A | 3 | ||
DNA topoisomerase 2α | 6 | ||
Droperidol | D2 dopamine receptor | 3 | 1 |
α2 adrenergic receptor | 5 | ||
levomethadyl Acetate | μAceta opioid receptor | 1 | 27 |
Neuronal acetylcholine receptor | 3 | ||
Lidoflazine | Calcium channel | 1 | 21 |
Terodiline | Calcium channel | 47 | 4 |